Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

What to do when standard treatment fails?

BSH 2017

27 - 29 Apr 2017

Sorry, this item is currently unavailable.

Published: 14 Jul 2017

Views: 1450

Rating:

Save

Dr Christopher Fox - Nottingham University Hospitals, Nottingham, UK

Dr Fox speaks at the 'measuring success in indolent disease' session during BSH 2017 in Brighton, UK.

Fox discusses what to do when standard treatment fails.

The content available here was filmed at a Roche Products Limited promotional symposium and contains discussion of Roche medicines.

Related Videos

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )

Special Issue on paediatric oncology

Prof Tezer Kutluk - Hacettepe University Faculty of Medicine & Cancer Institute...

Special Issue on paediatric oncology ( Prof Tezer Kutluk - Hacettepe University Faculty of Medicine & Cancer Institute, Sıhhiye-Ankara, Turkey )

Multiple myeloma in a resource constrained setting

Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda

Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and...

Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects ( Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal )

Relapsed Refractory Multiple Myeloma

Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India

$Relapsed Refractory Multiple Myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )$

CAR-T therapy and impact to cancer patient outcomes and experience of treatment

Mr Matthias Hellberg-Naegele - Cantonal Hospital St Gallen, St Gallen...

CAR-T therapy and impact to cancer patient outcomes and experience of treatment ( Mr Matthias Hellberg-Naegele - Cantonal Hospital St Gallen, St Gallen, Switzerland )

The current status of multiple myeloma diagnosis and treatment

Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina

The current status of multiple myeloma diagnosis and treatment ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

Systemic anti-cancer performance matrix

Prof Richard Sullivan, Kari Leung and Megan McLeod

Systemic anti-cancer performance matrix ( Prof Richard Sullivan, Kari Leung and Megan McLeod )

More from ecancer